Response of Esophageal Cancer Cells to Epigenetic Inhibitors is Mediated Via Altered Thioredoxin Activity

Overview

Journal Lab Invest

Specialty Pathology

Date 2015 Dec 23

PMID 26692290

Citations 9

Authors

Theresa D Ahrens

Sylvia Timme

Jenny Ostendorp

Lioudmilla Bogatyreva

Jens Hoeppner

Ulrich T Hopt

Dieter Hauschke

Martin Werner

Silke Lassmann

Affiliations

Soon will be listed here.

Abstract

We previously showed that histone deacetylase inhibitor (HDACi) and 5-azacytidine (AZA) treatment selectively induced cell death of esophageal cancer cells. The mechanisms of cancer selectivity, however, remained unclear. Here we examined whether the cancer selectivity of HDACi/AZA treatment is mediated by the thioredoxin (Trx) system and reactive oxygen species (ROS) in esophageal cancer cells. For this, we first analyzed human tissue specimens of 37 esophageal cancer patients by immunohistochemistry for Trx, Trx-interacting protein (TXNIP) and Trx reductase (TXNRD). This revealed a loss or at least reduction of nuclear Trx in esophageal cancer cells, compared with normal epithelial cells (P<0.001). Although no differences were observed for TXNIP, TXNRD was more frequently expressed in cancer cells (P<0.001). In the two main histotypes of esophageal squamous cell carcinomas (ESCCs, n=19) and esophageal adenomcarcinomas (EAC, n=16), similar Trx, TXNIP and TXNRD expression patterns were observed. Also in vitro, nuclear Trx was only detectable in non-neoplastic Het-1A cells, but not in OE21/ESCC or OE33/EAC cell lines. Moreover, the two cancer cell lines showed an increased Trx activity, being significant for OE21 (P=0.0237). After treatment with HDACi and/or AZA, ROS were exclusively increased in both cancer cell lines (P=0.048-0.017), with parallel decrease of Trx activity. This was variably accompanied by increased TXNIP levels upon AZA, MS-275 or MS-275/AZA treatment for 6 or 24 h in OE21, but not in Het-1A or OE33 cells. In summary, this study evaluated Trx and its associated proteins TXNIP and TXNRD for the first time in esophageal cancers. The analyses revealed an altered subcellular localization of Trx and strong upregulation of TXNRD in esophageal cancer cells. Moreover, HDACi and AZA disrupted Trx function and induced accumulation of ROS with subsequent apoptosis in esophageal cancer cells exclusively. Trx function is hence an important cellular mediator conferring non-neoplastic cell resistance for HDACi and/or AZA.

Citing Articles

New 4,5-Diarylimidazol-2-ylidene-iodidogold(I) Complexes with High Activity against Esophageal Adenocarcinoma Cells.

Schleser S, Ghosh H, Horner G, Seib J, Bhattacharyya S, Weber B Int J Mol Sci. 2023; 24(6).

PMID: 36982817 PMC: 10052191. DOI: 10.3390/ijms24065738.

Downregulation of miR-135b-5p Suppresses Progression of Esophageal Cancer and Contributes to the Effect of Cisplatin.

Di Y, Jiang Y, Shen X, Liu J, Gao Y, Cai H Front Oncol. 2021; 11:679348.

PMID: 34277424 PMC: 8281352. DOI: 10.3389/fonc.2021.679348.

mTOR-Mediated Antioxidant Activation in Solid Tumor Radioresistance.

Woo Y, Lee H, Jung Y, Jung Y J Oncol. 2020; 2019:5956867.

PMID: 31929797 PMC: 6942807. DOI: 10.1155/2019/5956867.

Synergistic induction of apoptosis in a cell model of human leukemia K562 by nitroglycerine and valproic acid.

Aalaei S, Mohammadzadeh M, Pazhang Y EXCLI J. 2019; 18:619-630.

PMID: 31611745 PMC: 6785758. DOI: 10.17179/excli2019-1581.

High Content Screening Characterization of Head and Neck Squamous Cell Carcinoma Multicellular Tumor Spheroid Cultures Generated in 384-Well Ultra-Low Attachment Plates to Screen for Better Cancer Drug Leads.

Kochanek S, Close D, Johnston P Assay Drug Dev Technol. 2018; 17(1):17-36.

PMID: 30592624 PMC: 6352515. DOI: 10.1089/adt.2018.896.

References

Liu J, Liu Q, Wei H, Yi J, Zhao H, Gao L . Inhibition of thioredoxin reductase by auranofin induces apoptosis in adriamycin-resistant human K562 chronic myeloid leukemia cells. Pharmazie. 2011; 66(6):440-4. View

Lee J, Jeong E, Choi M, Kim S, Park J, Song S . Inhibition of histone deacetylase 10 induces thioredoxin-interacting protein and causes accumulation of reactive oxygen species in SNU-620 human gastric cancer cells. Mol Cells. 2010; 30(2):107-12. DOI: 10.1007/s10059-010-0094-z. View

Nagano M, Hatakeyama K, Kai M, Nakamura H, Yodoi J, Asada Y . Nuclear expression of thioredoxin-1 in the invasion front is associated with outcome in patients with gallbladder carcinoma. HPB (Oxford). 2012; 14(9):573-82. PMC: 3461382. DOI: 10.1111/j.1477-2574.2012.00482.x. View

Farina A, Cappabianca L, DeSantis G, Di Ianni N, Ruggeri P, Ragone M . Thioredoxin stimulates MMP-9 expression, de-regulates the MMP-9/TIMP-1 equilibrium and promotes MMP-9 dependent invasion in human MDA-MB-231 breast cancer cells. FEBS Lett. 2011; 585(20):3328-36. DOI: 10.1016/j.febslet.2011.09.023. View

Eriksson S, Prast-Nielsen S, Flaberg E, Szekely L, Arner E . High levels of thioredoxin reductase 1 modulate drug-specific cytotoxic efficacy. Free Radic Biol Med. 2009; 47(11):1661-71. DOI: 10.1016/j.freeradbiomed.2009.09.016. View

Fichter C, Herz C, Munch C, Opitz O, Werner M, Lassmann S . Occurrence of multipolar mitoses and association with Aurora-A/-B kinases and p53 mutations in aneuploid esophageal carcinoma cells. BMC Cell Biol. 2011; 12:13. PMC: 3094318. DOI: 10.1186/1471-2121-12-13. View

Hansen J, Watson W, Jones D . Compartmentation of Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA binding by thioredoxin-1. Toxicol Sci. 2004; 82(1):308-17. DOI: 10.1093/toxsci/kfh231. View

Ahrens T, Werner M, Lassmann S . Epigenetics in esophageal cancers. Cell Tissue Res. 2014; 356(3):643-55. DOI: 10.1007/s00441-014-1876-y. View

Woolston C, Storr S, Ellis I, Morgan D, Martin S . Expression of thioredoxin system and related peroxiredoxin proteins is associated with clinical outcome in radiotherapy treated early stage breast cancer. Radiother Oncol. 2011; 100(2):308-13. DOI: 10.1016/j.radonc.2011.05.029. View

10.

Toh Y, Yamamoto M, Endo K, Ikeda Y, Baba H, Kohnoe S . Histone H4 acetylation and histone deacetylase 1 expression in esophageal squamous cell carcinoma. Oncol Rep. 2003; 10(2):333-8. View

11.

Noike T, Miwa S, Soeda J, Kobayashi A, Miyagawa S . Increased expression of thioredoxin-1, vascular endothelial growth factor, and redox factor-1 is associated with poor prognosis in patients with liver metastasis from colorectal cancer. Hum Pathol. 2007; 39(2):201-8. DOI: 10.1016/j.humpath.2007.04.024. View

12.

Arner E, Holmgren A . Physiological functions of thioredoxin and thioredoxin reductase. Eur J Biochem. 2000; 267(20):6102-9. DOI: 10.1046/j.1432-1327.2000.01701.x. View

13.

Kakolyris S, Giatromanolaki A, Koukourakis M, Powis G, Souglakos J, Sivridis E . Thioredoxin expression is associated with lymph node status and prognosis in early operable non-small cell lung cancer. Clin Cancer Res. 2001; 7(10):3087-91. View

14.

Butler L, Zhou X, Xu W, Scher H, Rifkind R, Marks P . The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin. Proc Natl Acad Sci U S A. 2002; 99(18):11700-5. PMC: 129332. DOI: 10.1073/pnas.182372299. View

15.

Whibley C, McPhail K, Keyzers R, Maritz M, Leaner V, Birrer M . Reactive oxygen species mediated apoptosis of esophageal cancer cells induced by marine triprenyl toluquinones and toluhydroquinones. Mol Cancer Ther. 2007; 6(9):2535-43. DOI: 10.1158/1535-7163.MCT-06-0760. View

16.

Ahrens T, Timme S, Hoeppner J, Ostendorp J, Hembach S, Follo M . Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine. Epigenetics. 2015; 10(5):431-45. PMC: 4623041. DOI: 10.1080/15592294.2015.1039216. View

17.

Zhao S, Zhu S, Hao X, Li P, Zhang S . Effects of DNA methyltransferase 1 inhibition on esophageal squamous cell carcinoma. Dis Esophagus. 2011; 24(8):601-10. DOI: 10.1111/j.1442-2050.2011.01199.x. View

18.

Marzano C, Gandin V, Folda A, Scutari G, Bindoli A, Rigobello M . Inhibition of thioredoxin reductase by auranofin induces apoptosis in cisplatin-resistant human ovarian cancer cells. Free Radic Biol Med. 2007; 42(6):872-81. DOI: 10.1016/j.freeradbiomed.2006.12.021. View

19.

Zhu X, Huang C, Peng B . Overexpression of thioredoxin system proteins predicts poor prognosis in patients with squamous cell carcinoma of the tongue. Oral Oncol. 2011; 47(7):609-14. DOI: 10.1016/j.oraloncology.2011.05.006. View

20.

Woolston C, Deen S, Al-Attar A, Shehata M, Chan S, Martin S . Redox protein expression predicts progression-free and overall survival in ovarian cancer patients treated with platinum-based chemotherapy. Free Radic Biol Med. 2010; 49(8):1263-72. DOI: 10.1016/j.freeradbiomed.2010.07.008. View